Mar 03, 2020 / 04:20PM GMT
Doug Schenkel - Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
(technical difficulty)
Jacquie Ross from Illumina to the Cowen conference. As everybody here knows, Illumina's been the leading supplier of next-generation sequencing tools to the world for the past decade plus. We have a lot to get through over the next half hour. We'll see how far we get. But before we jump into it, thanks again for being here. Any opening remarks or we also have the safe harbor, right?
Francis A. deSouza - Illumina, Inc. - CEO, President & Director
Yes. So let me start by saying thank you, Doug, and the entire Cowen team for hosting us today. Thank all of you for making the time to be here.
Let me start by reading our safe harbor statement. I've been asked to remind you that my comments today could include forward-looking statements you should refer to our SEC filings for a discussion of the risks and uncertainties that could cause results to differ materially from our current expectations. It is our intent that all forward
Illumina Inc at Cowen HealthCare Conference Transcript
Mar 03, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers